SecBot SecBot
SECBOTREPLAY Home › Report › MRNA

MRNA · A Special Master in the District of Delaware denied GSK's motion to…

Moderna, Inc. · COURT-RULING filed Jun 15, 2026 at 20:00 ET

At the news

NEUTRALIMPACT 2/10

COURT-RULING filed Jun 15, 2026 at 20:00 ET

A Special Master in the District of Delaware denied GSK's motion to limit third-party inventor depositions to 10 combined hours across its patent infringement cases against Pfizer/BioNTech and Moderna. The ruling allows each defendant group up to 7 hours per inventor witness, preserving full examination rights for key inventors Dr. Geall and Dr. Mandl. This is a procedural discovery ruling with no financial exposure, no injunction, and no change to the underlying patent litigation merits.

  • GSK's motion to limit defendants to 10 combined hours of third-party inventor depositions was DENIED
  • Each defendant group (Pfizer/BioNTech and Moderna) retains the right to up to 7 hours per inventor witness under FRCP 30(d)(1)
  • The ruling concerns two key witnesses: Dr. Andrew Geall (named inventor on all asserted patents) and Dr. Christian Mandl
  • Fact discovery closes July 29, 2026, in all three related actions

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access